Taking out potential competition, drug maker says it will buy East Bay rival
April 30, 2018 at 16:52 PM EDT
The three-year-old company raised $40 million in an IPO with the promise of delivering an easy-to-use drug-device for people with high blood pressure in the lungs. Now it is moving toward a deal with a company it could have upended.